[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.168.204. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
February 16, 2000

Access to Antiretroviral Therapy

Author Affiliations
 

Phil B.FontanarosaMD, Deputy EditorIndividualAuthorStephen J.LurieMD, PhD, Fishbein FellowIndividualAuthor

JAMA. 2000;283(7):883-884. doi:10.1001/jama.283.7.882

To the Editor: Dr Shapiro and colleagues1 analyzed the care received by a cohort of more than 2000 US adults infected with human immunodeficiency virus (HIV). Suboptimal access to care was seen for blacks, Latinos, the uninsured, those insured by Medicaid, women, and persons with a presumed HIV exposure other than men who have had sex with men. For 696 persons included in the last group, the reported HIV exposure was injection drug use. However, no data are presented on the actual injection drug use at the time of the study, and whether these persons received care in opioid maintenance treatment programs (eg, methadone or heroin).

First Page Preview View Large
First page PDF preview
First page PDF preview
×